MATTHEW MESSINA: Open Payments
NPI 1861151961 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 34 payments from 6 companies in 2025. Trend: 2023 $423 · 2024 $434 · 2025 $969
Food & beverage: $901Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $559 |
| Antares Pharma, Inc. | 9 | $163 |
| Endo USA, Inc. | 7 | $147 |
| Astellas Pharma US Inc | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| TOLMAR, INC. | 1 | $18 |
Products named: RYBREVANT, ERLEADA, XYOSTED, AVEED, Xtandi, PLUVICTO, XIAFLEX, JATENZO.
Industry payments across FL — which companies pay providers there.
